NQO1 and ATBF1 in Breast Cancer: No Evidence of Target Genes for Chromosome 16q Loss
Author Information
Author(s): Cleton-Jansen Anne-Marie, van Eijk Ronald, Lombaerts Marcel, Schmidt Marjanka K, Van't Veer Laura J, Philippo Katja, Zimmerman Rhyenne ME, Peterse Johannes L, Smit Vincent TBHM, van Wezel Tom, Cornelisse Cees J
Primary Institution: Leiden University Medical Centre
Hypothesis
The study aimed to identify tumor suppressor genes at chromosome arm 16q in breast cancer.
Conclusion
NQO1 and ATBF1 were identified as candidate tumor suppressor genes, but further analysis showed they are not targets of loss of heterozygosity.
Supporting Evidence
- NQO1 and ATBF1 showed reduced expression in tumors with LOH at 16q.
- Immunohistochemical analysis revealed higher NQO1 protein expression in some breast tumors compared to normal tissue.
- Variants in ATBF1 were found in both tumor and normal tissues, indicating they are not somatic mutations.
Takeaway
Researchers looked for important genes in breast cancer but found that two candidates, NQO1 and ATBF1, are not the culprits for the genetic changes seen in tumors.
Methodology
The study used a cDNA microarray to analyze RNA from breast tumors with known loss of heterozygosity status.
Limitations
The study did not identify somatic mutations in ATBF1 and questioned the pathogenic nature of previously reported variants.
Participant Demographics
The study included 39 breast tumor samples with known LOH status.
Statistical Information
P-Value
0.005
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website